Vitamin D: are all compounds equal?
Study Goal
The researchers aimed to review the role of Vitamin D in mineral homeostasis and its therapeutic applications, particularly in chronic kidney disease (CKD) patients, focusing on deficiency management and secondary hyperparathyroidism.
Results Summary
The study highlights Vitamin D's importance in bone, cardiovascular, and renal health, noting its deficiency prevalence in CKD patients. It discusses the evolution of Vitamin D treatment options, emphasizing tailored approaches for CKD management, though debates remain about its impact on bone health and clinical outcomes.
Population
Chronic kidney disease (CKD) patients and the general population.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Vitamin D | neutral | mineral homeostasis | - | - | essential for maintaining | #1 |
Vitamin D | neutral | bone, cardiovascular and renal health | - | - | plays significant roles in | #2 |
Vitamin D deficiency | increase | mineral and bone disorder | chronic kidney disease (CKD) patients | - | contributes to the development and progression of | #3 |
pharmacological vitamin D products | decrease | vitamin D deficiency | CKD patients | - | can be strategically used to address | #4 |
pharmacological vitamin D products | decrease | secondary hyperparathyroidism | CKD patients | - | can be strategically used to address | #5 |
Vitamin D is a pre-hormone essential for maintaining mineral homeostasis and also plays significant roles in bone, cardiovascular and renal health. Vitamin D deficiency is prevalent in the general population, and even more so in chronic kidney disease (CKD) patients, in which it contributes to the development and progression of mineral and bone disorder. The landscape of vitamin D treatment has evolved, with several analogues now available, each possessing distinct pharmacokinetic and pharmacodynamic properties, efficacies and safety profiles. This diversity allows for tailored, personalized approaches to treatment in CKD patients. This review aims to provide a comprehensive overview of vitamin D, including its natural sources and metabolism, and examines the main available pharmacological vitamin D products. Particular emphasis is placed on their application in CKD management, highlighting how these compounds can be strategically used to address both vitamin D deficiency and secondary hyperparathyroidism, while also acknowledging the ongoing debate about their impact on bone health and other clinical outcomes.